Methicillin-resistant Staphylococcus aureus nasal colonization in children in Jerusalem: community vs. chronic care

Yechiel Schlesinger1, Shira Yahalom, David Raveh

  • 1Infectious Diseases Unit, Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel. yechiel@szmc.org.il

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization is low in healthy Jerusalem children but significantly higher in those in chronic care. Risk factors included older age and healthcare worker family members.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Public health

Background:

  • Community nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) is increasing.
  • Limited data exists on MRSA colonization in children within chronic care institutions and Israeli pediatric populations.

Purpose of the Study:

  • Determine MRSA nasal colonization rates in healthy Jerusalem children.
  • Compare colonization rates with chronically institutionalized children.
  • Identify risk factors for MRSA colonization.
  • Differentiate community-acquired vs. hospital-acquired MRSA strains.

Main Methods:

  • Nasal swabs collected from 831 healthy children and 118 chronically institutionalized children in Jerusalem.
  • Cultures performed for methicillin-sensitive and methicillin-resistant S. aureus (MRSA).
  • Pulsed field gel electrophoresis (PFGE) used to analyze strain patterns.

Main Results:

  • S. aureus colonization: 23.5% in healthy children vs. 36.4% in institutionalized children.
  • MRSA colonization: 2.6% in healthy children vs. 21% in institutionalized children (P < 0.001).
  • Risk factors for S. aureus: older age, family member in healthcare (healthy children); older age (institutionalized children).
  • Antibiotic susceptibility and PFGE patterns were similar between groups.

Conclusions:

  • MRSA nasal colonization is low in the general pediatric population in Jerusalem.
  • Chronically institutionalized children exhibit significantly higher MRSA colonization rates.
  • No significant differences found in antibiotic susceptibility or strain patterns between community-acquired and hospital-acquired MRSA.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...